Showing 1 - 10 of 920
disease mortality across states over time. The results show that there is a causal link between health and income per person …
Persistent link: https://www.econbiz.de/10012124859
The health status of people is a precious commodity and central to economic, socio-political, and environmental dimensions of any country. Yet it is often the missing statistic in all general statistics, demographics, and presentations about the portrait of immigrants and natives. In this paper...
Persistent link: https://www.econbiz.de/10011735974
The aim of this paper is to study the long-run effects of a longevity increase on individual decisions about education …
Persistent link: https://www.econbiz.de/10010528342
This paper examines the extent to which changes in working-age shares associated with population aging might slow economic growth in upcoming years. We first analyze the economic effects of changing working-age shares in a standard empirical growth model using country panel data from 1950-2015....
Persistent link: https://www.econbiz.de/10014332127
We propose an innovation-driven growth model in which education is determined by family background and cognitive … ability. We show that compulsory schooling can move a society from elite education to mass education, which then triggers …, compulsory education is implemented first and triggers the onset of market R&D. According to the British way, market R&D is …
Persistent link: https://www.econbiz.de/10011392484
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is estimated to have increased mean age at death by...
Persistent link: https://www.econbiz.de/10009571756
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at death), hospital utilization, and medical expenditure in Greece during the period 1995 - 2010. The estimates indicate that pharmaceutical innovation increased mean age at death...
Persistent link: https://www.econbiz.de/10010473542
We investigate how an artist’s death impacts on the price of her artwork by estimating individual death effects of a sample of famous visual artists who died between 1985 and 2010. Using data from art auctions that took place in a narrow window around the artists’ death, we apply various...
Persistent link: https://www.econbiz.de/10012194643
In this paper, we develop a life cycle model in which health and longevity are threatened by infectious and chronic diseases. The model captures that the susceptibility and severity of infectious diseases depend on the accumulated health deficits (immunosenescence) and that the life history of...
Persistent link: https://www.econbiz.de/10013472349
In this paper, we examine the effects of the Covid-19 pandemic on individual aging and longevity with special focus on socioeconomic disparities in health outcomes. We also explore the individual-specific effects of Long Covid. We develop and calibrate a health economic model based on principles...
Persistent link: https://www.econbiz.de/10014529184